GoAI
Get started
WOLVES HAND Co., Ltd. logo

WOLVES HAND Co., Ltd.

194A.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥1,885

−¥98.00 · -4.94%

Aug 24, 3:30 PM JST

194A.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

WOLVES HAND Co., Ltd., an Osaka-based company established in 1999, primarily manages and operates veterinary hospitals throughout Japan. Its diversified services also encompass pet grooming salons, animal boarding facilities, and educational workshops for veterinary professionals.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Masashi Kitai
Listed since
Jun 20, 2024
Employees
453

Market position

Day range

Current ¥1,885

52-week range

Current ¥1,885

Open
¥1,974
Previous close
¥1,983
Volume
22.4K
0.62× average
Average volume
36.33K
Average daily volume
Market cap
14.23B JPY
Beta
1.14
Market reference 1
50-day average
¥1,518.24
+24.16% above average
200-day average
¥1,708.76
+10.31% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
11.55B JPY
P/E (TTM)
15.11×
P/B (TTM)
3.82×
P/S (TTM)
2.31×
EV / EBITDA
7.86×
Earnings yield
9.05%
Free cash flow yield
9.00%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
27.22%
Operating margin
18.31%
Net margin
15.26%
Return on equity
25.26%
Return on assets
13.88%
Return on invested capital
13.17%

Financial health

Debt / equity
0.53×
Current ratio
1.59×
Altman Z-score
4.7
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends29%21%13%5%Gross margin, FY2022: 25.16%Gross margin, FY2023: 24.59%Gross margin, FY2024: 24.57%Gross margin, FY2025: 24.14%Gross margin, FY2026: 27.22%Operating margin, FY2022: 16.17%Operating margin, FY2023: 17.27%Operating margin, FY2024: 16.58%Operating margin, FY2025: 15.88%Operating margin, FY2026: 17.63%Net margin, FY2022: 7.38%Net margin, FY2023: 10.88%Net margin, FY2024: 11.19%Net margin, FY2025: 10.85%Net margin, FY2026: 15.26%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 25.16%. Gross margin FY2023 24.59%. Gross margin FY2024 24.57%. Gross margin FY2025 24.14%. Gross margin FY2026 27.22%. Operating margin FY2022 16.17%. Operating margin FY2023 17.27%. Operating margin FY2024 16.58%. Operating margin FY2025 15.88%. Operating margin FY2026 17.63%. Net margin FY2022 7.38%. Net margin FY2023 10.88%. Net margin FY2024 11.19%. Net margin FY2025 10.85%. Net margin FY2026 15.26%.

Income trends

Revenue

6.16B JPY+12.67%

Operating income

1.09B JPY+25.08%

Net income

939.4M JPY+58.41%
Income trends across reported periods6.74B JPY4.4B JPY2.07B JPY−267.05M JPYRevenue, FY2022: 4.3B JPYRevenue, FY2023: 4.65B JPYRevenue, FY2024: 4.99B JPYRevenue, FY2025: 5.46B JPYRevenue, FY2026: 6.16B JPYOperating income, FY2022: 694.69M JPYOperating income, FY2023: 803.31M JPYOperating income, FY2024: 827.47M JPYOperating income, FY2025: 867.46M JPYOperating income, FY2026: 1.09B JPYNet income, FY2022: 316.87M JPYNet income, FY2023: 506.13M JPYNet income, FY2024: 558.41M JPYNet income, FY2025: 593.02M JPYNet income, FY2026: 939.4M JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 4.3B JPY. Revenue FY2023 4.65B JPY. Revenue FY2024 4.99B JPY. Revenue FY2025 5.46B JPY. Revenue FY2026 6.16B JPY. Operating income FY2022 694.69M JPY. Operating income FY2023 803.31M JPY. Operating income FY2024 827.47M JPY. Operating income FY2025 867.46M JPY. Operating income FY2026 1.09B JPY. Net income FY2022 316.87M JPY. Net income FY2023 506.13M JPY. Net income FY2024 558.41M JPY. Net income FY2025 593.02M JPY. Net income FY2026 939.4M JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue6.16B JPY5.46B JPY4.99B JPY4.65B JPY4.3B JPY
Cost of goods sold4.48B JPY4.15B JPY3.76B JPY3.51B JPY3.21B JPY
Gross profit1.68B JPY1.32B JPY1.23B JPY1.14B JPY1.08B JPY
Selling, general, and administrative590.88M JPY451.31M JPY398.96M JPY340.32M JPY359.75M JPY
Operating expenses590.88M JPY451.31M JPY398.96M JPY340.32M JPY385.75M JPY
Interest expense27.6M JPY24.53M JPY15.7M JPY15.16M JPY14.05M JPY
Depreciation and amortization384.67M JPY350.21M JPY322.77M JPY315.75M JPY336.99M JPY
Operating income1.09B JPY867.46M JPY827.47M JPY803.31M JPY694.69M JPY
Net income939.4M JPY593.02M JPY558.41M JPY506.13M JPY316.87M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
45.3

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates47.636.4725.3314.2Q2 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q2 2025, reported May 15, 2025: actual 16.5, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual 39.06, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 17.95, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual 39.49, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 13, 2026: actual 45.3, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.91B1.68B1.45B1.22BQ2 '25No estimateQ4 '25No estimateQ1 '26BeatQ2 '26BeatQ3 '26Beat
Q2 2025, reported May 15, 2025: actual 1.29B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual 1.37B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 1.43B JPY, estimate 1.39B JPY, surprise +3.48%, Beat. Q2 2026, reported May 13, 2026: actual 1.52B JPY, estimate 1.4B JPY, surprise +8.57%, Beat. Q3 2026, reported Aug 13, 2026: actual 1.84B JPY, estimate 1.8B JPY, surprise +2.06%, Beat.

Corporate actions

Corporate action history

DividendUpcoming

Ex-dividend Jun 29, 2027

¥26.00

Irregular

Record Jun 30, 2027 · Payment Jun 29, 2027

194A.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 194A.T

research.disclaimer